The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 4,001–4,100 of 31,469
Gao, H., Wen, J.-J., Hu, J., Nie, Q., Chen, H., Xiong, T., Nie, S., & Xie, M. (2019) · Food Research International · doi:10.1016/j.foodres.2019.03.055 · Cited by 84
Alferink, L. J. M., Trajanoska, K., Erler, N. S., Schoufour, J. D., de Knegt, R. J., Ikram, M. A., Janssen, H. L. A., Franco, O. H., Metselaar, H. J., Rivadeneira, F., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3713 · Cited by 85
Goh, C. E., Trinh, P., Colombo, P. C., Genkinger, J. M., Mathema, B., Uhlemann, A., LeDuc, C. A., Leibel, R. L., Rosenbaum, M. S., Paster, B. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013324 · Cited by 87
Fahed, M., Jaoude, M. A., Merhi, S., Boumosleh, J. M., Ghadieh, R., Hayek, S. A., & Fares, J. E. H. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00558-9 · Cited by 90
Zhang, L., Zhang, Y., Shen, S., Wang, X., Dong, L., Li, Q., Ren, W., Li, Y., Bai, J., Gong, Q., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00132-8 · Cited by 92
Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis
Behnoush, A. H., Khalaji, A., Ghondaghsaz, E., Masrour, M., Varniab, Z. S., Khalaji, S., & Cannavò, A. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02005-3 · Cited by 86
Circadian desynchrony and glucose metabolism
Speksnijder, E. M., Bisschop, P. H. L. T., Siegelaar, S. E., Stenvers, D. J., & Kalsbeek, A. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12956 · Cited by 100
Yin, J.-L., Yang, J., Song, X., Qin, X., Chang, Y.-J., Chen, X., Liu, F.-H., Li, Y.-Z., Xu, H.-L., Wei, Y., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02241-y · Cited by 90
Soares, G. M., Vieira, C. S., Martins, W. P., Franceschini, S. A., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03506.x · Cited by 80
Graul-Neumann, L. M., Kienitz, T., Robinson, P. N., Baasanjav, S., Karow, B., Gillessen‐Kaesbach, G., Fahsold, R., Schmidt, H., Hoffmann, K., & Passarge, E. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33690 · Cited by 83
Association Between Insulin Resistance and Bone Mass in Men
Shin, D., Kim, S., Kim, K. H., Lee, K., & Park, S. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3338 · Cited by 84
Zhao, Y. L., Jiang, Z., Zhao, T., Ye, M., Hu, C., Zhou, H., Yin, Z., Chen, Y., Zhang, Y., Wang, S., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-160 · Cited by 84
British South Asians aged 13–16 years have higher fasting glucose and insulin levels than Europeans
Whincup, P. H., Gilg, J. A., Owen, C. G., Odoki, K., Alberti, K. G. M. M., & Cook, D. G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01587.x · Cited by 82
Ohuchi, H., Miyamoto, Y., Yamamoto, M., Ishihara, H., Takata, H., Miyazaki, A., Yamada, O., & Yagihara, T. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.04.021 · Cited by 83
Habib, S. A., Saad, E. A., Elsharkawy, A. A., & Attia, Z. R. (2015) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.02.002 · Cited by 83
Chang, J.-W., Chen, H., Su, H.-J. J., Liao, P.-C., Guo, H., & Lee, C.-C. (2010) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2010.09.084 · Cited by 83
Campanati, A., Ganzetti, G., Sario, A. D., Damiani, A., Sandroni, L., de la Rosa, L. E. S., Benedetti, A., & Offidani, A. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0678-9 · Cited by 82
Chari, S. T., Zapiach, M., Yadav, D., & Rizza, R. A. (2005) · Pancreatology · doi:10.1159/000085276 · Cited by 83
Retnakaran, R. R., Youn, B., Liu, Y., Hanley, A. J., Lee, N. S., Park, J. W., Song, E. S., Vu, V. P., Kim, W. I., Tungtrongchitr, R., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03264.x · Cited by 82
Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors
Burgert, T. S., Dziura, J., Yeckel, C. W., Taksali, S. E., Weiss, R., Tamborlane, W. V., & Caprio, S. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803136 · Cited by 83
Huang, R., Beilin, L. J., Ayonrinde, O. T., Mori, T. A., Olynyk, J. K., Burrows, S., Hands, B. P., & Adams, L. A. (2013) · Hepatology · doi:10.1002/hep.26495 · Cited by 83
Cole, S. A., Butte, N. F., Voruganti, V. S., Cai, G., Haack, K., Kent, J. W., Blangero, J., Comuzzie, A. G., McPherson, J. D., & Gibbs, R. A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28514 · Cited by 83
Reinehr, T., de Sousa, G., & Andler, W. (2005) · Obesity Research · doi:10.1038/oby.2005.222 · Cited by 83
Effects of atorvastatin on inflammation and oxidative stress
Sugiyama, M., Ohashi, M., Takase, H., Sato, K., Ueda, R., & Dohi, Y. (2005) · Heart and Vessels · doi:10.1007/s00380-005-0833-9 · Cited by 83
Grøntved, A., Ried-Larsen, M., Ekelund, U., Froberg, K., Brage, S., & Andersen, L. (2013) · Diabetes Care · doi:10.2337/dc12-2252 · Cited by 68
Hamza, N., Berke, B., Chèze, C., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.01.004 · Cited by 83
Magni, P., Liuzzi, A., Ruscica, M., Dozio, E., Ferrario, S., Bussi, I., Minocci, A., Castagna, A., Motta, M., & Savia, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02195.x · Cited by 82
Familial Early-Onset Type 2 Diabetes in Chinese Patients
Ng, M. C. Y., Lee, S., Ko, G. T. C., Li, J. K. Y., So, W., Hashim, Y., Barnett, A. H., Mackay, I. R., Critchley, J., Cockram, C. S., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.663 · Cited by 83
Lim, S. K., Shin, H., Kim, M. J., Ahn, H. Y., Kang, S. M., Yoon, J. W., Choi, S. H., Kim, K. W., Song, J. H., Choi, S. I., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1580 · Cited by 85
Marinangeli, C. P. F., & Jones, P. J. H. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003156 · Cited by 83
Rosiglitazone RECORD study: glucose control outcomes at 18 months
Home, P., Jones, N. P., Pocock, S., Beck‐Nielsen, H., Gomis, R., Markolf Hanefeld, E., Michel Komajda, N., Curtis, P. S., & for the RECORD Study Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02160.x · Cited by 82
Chen, G., Bentley, A. R., Adeyemo, A., Shriner, D., Zhou, J., Doumatey, A. P., Huang, H., Ramos, E., Erdos, M. R., Gerry, N. P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds282 · Cited by 83
Tarantino, G., Conca, P., Riccio, A., Tarantino, M., Minno, M. N. D. D., Chianese, D., Pasanisi, F., Contaldo, F., Scopacasa, F., & Capone, D. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-72 · Cited by 84
Zhang, D., Zhang, L., Yue, F., Zheng, Y., & Russell, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0589 · Cited by 86
Biering, H., Saller, B., Bauditz, J., Pirlich, M., Rudolph, B., Johne, A., Buchfelder, M., Mann, K., Droste, M., Schreiber, I., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02079 · Cited by 80
Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1
Crandall, D. L., Quinet, E. M., Ayachi, S. E., Hreha, A. L., Leik, C. E., Savio, D. A., Juhan-Vague, I., & Alessi, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000235605.51400.9d · Cited by 84
Rudovich, N. N., Rochlitz, H., & Pfeiffer, A. F. H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2359 · Cited by 85
Almoosawi, S., Tsang, C., Ostertag, L. M., Fyfe, L., & Al‐Dujaili, E. A. S. (2012) · Food & Function · doi:10.1039/c2fo30060e · Cited by 83
The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects
Nagel, J. M., Tietz, A. B., Göke, B., & Parhofer, K. G. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.011 · Cited by 83
Bo, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i45.7109 · Cited by 83
Takatsu, M., Nakashima, C., Takahashi, K., Murase, T., Hattori, T., Ito, H., Murohara, T., & Nagata, K. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02093 · Cited by 82
The association between liver enzymes and risk of type 2 diabetes: the Namwon study
Ahn, H.-R., Shin, M., Nam, H., Park, K.-S., Lee, Y. H., Jeong, S., Choi, J., & Kweon, S. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-14 · Cited by 83
Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
Åhrén, B. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1944 · Cited by 84
Arterial Destiffening With Atorvastatin in Overweight and Obese Middle-Aged and Older Adults
Orr, J. S., Dengo, A. L., Rivero, J. M., & Davy, K. P. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138248 · Cited by 83
Mika Kivimaki, B., Lawlor, D. A., Juonala, M., Smith, G. D., Elovainio, M. J., Keltikangas‐Järvinen, L., Vahtera, J., Viikari, J. S. A., & Raitakari, O. T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183729.91449.6e · Cited by 84
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
Turola, E., Petta, S., Vanni, E., Milosa, F., Valenti, L. V. C., Critelli, R. M., Miele, L., Macciò, L., Calvaruso, V., Fracanzani, A. L., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019950 · Cited by 88
Intake of phthalate-tainted foods and microalbuminuria in children: The 2011 Taiwan food scandal
Tsai, H., Chen, B., Wu, C., Wang, S., Huang, P., Tsai, Y., Chen, M.-L., Ho, C., Hsiung, C. A., & Wu, M. (2016) · Environment International · doi:10.1016/j.envint.2016.01.015 · Cited by 83
Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat
Oh, S. W., Han, K. H., Han, S. Y., Koo, H., Kim, S., & Chin, H. J. (2015) · Medicine · doi:10.1097/md.0000000000001650 · Cited by 81
Parr, E. B., CAMERA, D. M., Burke, L. M., Phillips, S. M., Coffey, V. G., & Hawley, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152545 · Cited by 91
Chou, P., Lin, K.-C., Lin, H.-Y., & Tsai, S. (2001) · PubMed · Cited by 84
Bastos, A. D. S., Graves, D. T., Loureiro, A. P. D. M., Rossa, C., Corbi, S. C. T., Frizzera, F., Scarel‐Caminaga, R. M., Câmara, N. O. S., Andriankaja, O. M., Hiyane, M. I., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.011 · Cited by 84
Ma, J., Jacques, P. F., Meigs, J. B., Fox, C. S., Rogers, G. T., Smith, C. E., Hruby, A., Saltzman, E. J., & McKeown, N. M. (2016) · Journal of Nutrition · doi:10.3945/jn.116.234047 · Cited by 89
Hyogo, H., Ikegami, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tokumo, H., Hino, F., & Tazuma, S. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00849.x · Cited by 83
Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA)
Carlsson, Å., Sundkvist, G., Groop, L., & Tuomi, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6228 · Cited by 98
Effect of weight loss on muscle lipid content in morbidly obese subjects
Gray, R. E., Tanner, C. J., Pories, W. J., MacDonald, K. G., & Houmard, J. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2002 · Cited by 81
White-Coat Hypertension and Carotid Artery Atherosclerosis
Muldoon, M. F., Nazzaro, P., Sutton‐Tyrrell, K., & Manuck, S. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1507 · Cited by 81
AlKhairi, I., Cherian, P., Abu-Farha, M., Madhoun, A. A., Nizam, R., Melhem, M., Jamal, M., Al-Sabah, S., Ali, H., Tuomilehto, J., et al. (2019) · Cells · doi:10.3390/cells8101283 · Cited by 82
Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
Hahn, S., Kuehnel, W., Tan, S., Kramer, K., Schmidt, M., Roesler, S., Kimmig, R., Mann, K., & Janssen, O. E. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.031 · Cited by 82
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82
Fenkçi, S. M., Sarsan, A., Rota, S., & Ardıç, F. (2006) · Advances in Therapy · doi:10.1007/bf02850161 · Cited by 82
Amin, M. M., Asaad, G. F., Abdelsalam, R. M., El-Abhar, H. S., & Arbid, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089169 · Cited by 83
Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis
Leach, N. V., Dronca, E., Vesa, Ș. C., Sâmpelean, D., Crăciun, E. C., Lupșor‐Platon, M., Crișan, D., Tarau, R., Rusu, R., Para, I., et al. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.09.007 · Cited by 83
Melistas, L., Mantzoros, C. S., Kontogianni, M. D., Antonopoulou, S., Ordovás, J. M., & Yiannakouris, N. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0492 · Cited by 82
for the ERASE METS Study Investigators, Adachi, H., Nakano, H., et al. (2015) · Lipids in Health and Disease · doi:10.1186/1476-511x-14-1 · Cited by 82
Barbosa, P. O., Pala, D., Silva, C. T., de Souza, M. O., do Amaral, J. F., Vieira, R. A. L., Folly, G. A. D. F., Volp, A. C. P., & de Freitas, R. N. (2015) · Nutrition · doi:10.1016/j.nut.2015.12.030 · Cited by 83
Swift, D. L., Johannsen, N. M., Lavie, C. J., Earnest, C. P., Blair, S. N., & Church, T. S. (2016) · Obesity · doi:10.1002/oby.21404 · Cited by 83
Peter, A., Kovářová, M., Staiger, H., Machann, J., Schick, F., Königsrainer, A., Königsrainer, I., Schleicher, E. D., Fritsche, A., Häring, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2017 · Cited by 83
de Bem, G. F., da Costa, C. A., Santos, I. B., Cordeiro, V. S. C., de Carvalho, L. C. R. M., de Souza, M. A. V., Soares, R. D. A., Sousa, P. J. C., Ognibene, D. T., Resende, Â. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199207 · Cited by 82
Tang, D., Liu, L., Ajiakber, D., Ye, J., Xu, J., Xin, X., & Aisa, H. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00586 · Cited by 85
Metformin upregulates mitophagy in patients with T2DM: A randomized placebo‐controlled study
Bhansali, S., Bhansali, A. K., Dutta, P. R., Walia, R., & Dhawan, V. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14834 · Cited by 82
Lim, S. K., Moon, J. H., Shin, C., Jeong, D., & Kim, B. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.425 · Cited by 84
Kim, Y. M., Kim, J., Park, J. S., Baik, S. J., Chun, J., Youn, Y. H., & Park, H. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01222-4 · Cited by 83
Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats
Ibrahim, Y. F., Alorabi, M., Abdelzaher, W. Y., Toni, N. D. M., Thabet, K., Hegazy, A., Bahaa, H. A., Batiha, G. E., Welson, N. N., Morsy, M. A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112870 · Cited by 86
Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome
Hu, L., Ma, L., Xia, X., Ying, T., Zhou, M., Zou, S., Yu, H., & Yin, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac294 · Cited by 93
Tsai, S., Yang, C., Liu, W.-J., & Lee, C.-L. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101934 · Cited by 89
Castro, M. C., Massa, M. L., Arbeláez, L. F. G., Schinella, G. R., Gagliardino, J. J., & Francini, F. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.07.010 · Cited by 82
Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland
Viljakainen, H. T., Andersson‐Assarsson, J. C., Armenio, M., Pekkinen, M., Pettersson, M., Valta, H., Lipsanen‐Nyman, M., Mäkitie, O., & Lindstrand, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131883 · Cited by 83
Rozing, M. P., Westendorp, R. G. J., de Craen, A. J. M., Frölich, M., de Goeij, M. C. M., Heijmans, B. T., Beekman, M., Wijsman, C. A., Mooijaart, S. P., Blauw, G. J., et al. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02725.x · Cited by 83
Barrea, L., Macchia, P. E., Tarantino, G., Somma, C. D., Pane, E., Balato, N., Napolitano, M., Colao, A., & Savastano, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0658-y · Cited by 83
Cho, L., Kilpatrick, E. S., Keevil, B. G., Coady, A., & Atkin, S. L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03309.x · Cited by 82
Yoshida, M., McKeown, N. M., Rogers, G. T., Meigs, J. B., Saltzman, E. J., D’Agostino, R. B., & Jacques, P. F. (2007) · Journal of Nutrition · doi:10.1093/jn/137.9.2121 · Cited by 84
MacKenzie, T. A., Comi, R. J., Sluss, P. M., Keisari, R., Manwar, S., Kim, J., Larson, R. J., & Baron, J. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.013 · Cited by 83
Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat
Balbo, S. L., Grassiolli, S., Ribeiro, R. A., Bonfleur, M. L., Gravena, C., Brito, M. D. N., Andreazzi, A. E., Mathias, P. C. D. F., & Torrezan, R. (2007) · Endocrine · doi:10.1007/s12020-007-0021-z · Cited by 82
Asthma and Insulin Resistance in Morbidly Obese Children and Adolescents
Al-Shawwa, B. A., Al-Huniti, N. H., DeMattia, L., & Gershan, W. M. (2007) · Journal of Asthma · doi:10.1080/02770900701423597 · Cited by 83
Krinninger, P., Ensenauer, R. E., Ehlers, K., Rauh, K., Stoll, J., Krauss‐Etschmann, S., Hauner, H., & Laumen, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2611 · Cited by 85
Carulli, L., Ballestri, S., Lonardo, A., Lami, F., Violi, E., Losi, L., Bonilauri, L., Verrone, A. M., Odoardi, M. R., Scaglioni, F., et al. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0609-4 · Cited by 80
Jin, H., Jiang, B., Tang, J., Lu, W., Wang, W., Zhou, L., Shang, W., Li, F., Ma, Q., Yang, Y., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.019 · Cited by 82
Gadgil, M. D., Anderson, C. A. M., Kandula, N. R., & Kanaya, A. M. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.09.021 · Cited by 88
Park, T.-G., Hong, H.-R., Lee, J., & Kang, H. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000104137 · Cited by 85
Hung, J.-W., Liou, C., Wang, P., Yeh, S., Lin, L., Lo, S. K., & Tsai, F. (2009) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0445 · Cited by 84
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
Martínez‐González, M. Á., Ros, E., & Estruch, R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-1-200701020-00019 · Cited by 82
Chaves, G. V., Pereira, S., Saboya, C. J., & Ramalho, A. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9361-2 · Cited by 82
Appetite‐Regulating Hormone Changes in Patients With Craniopharyngioma
Roth, C. L., Gebhardt, U., & Müller, H. (2011) · Obesity · doi:10.1038/oby.2010.80 · Cited by 83
Tam, C. H. T., Ho, J. S. K., Wang, Y., Lee, H. M., Lam, V. K. L., Germer, S., Martin, M., So, W. Y., Ronald, C. W., Chan, J. C. N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011428 · Cited by 81
Sayın, O., Tokgöz, Y., & Arslan, N. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0296 · Cited by 82
Bakry, O., Shoeib, M. A., Shafiee, M. E., et al. (2014) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.137776 · Cited by 82
Petersson, H., Daryani, A., & Risérus, U. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-10 · Cited by 80
Effect of macronutrient intake during the second trimester on glucose metabolism later in pregnancy
Ley, S. H., Hanley, A. J., Retnakaran, R. R., Sermer, M., Zinman, B., & O’Connor, D. L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018861 · Cited by 84
Kılıçdağ, E. B., Bağış, T., Tarım, E., Aslan, E., Erkanlı, S., Şımşek, E., Haydardedeoğlu, B., & Kuşçu, E. (2005) · Human Reproduction · doi:10.1093/humrep/deh825 · Cited by 82
Genetic Variation in KCNQ1 Associates With Fasting Glucose andβ-Cell Function
Tan, J. T., Nurbaya, S., Gardner, D. S.-L., Ye, S., Tai, E. S., & Ng, D. P. K. (2009) · Diabetes · doi:10.2337/db08-1138 · Cited by 82
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
